PSCM
MRK icon

Per Stirling Capital Management’s Merck MRK Stock Holding History

Per Stirling Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$453K Buy
3,769
+132
+4% +$15.2K 0.05% 209
2025
Q4 		$383K Buy
3,637
+2
+0.1% +$188 0.04% 216
2025
Q3 		$305K Buy
3,635
+63
+2% +$5.19K 0.04% 224
2025
Q2 		$283K Sell
3,572
-311
-8% -$24.7K 0.04% 226
2025
Q1 		$349K Buy
3,883
+420
+12% +$39.2K 0.05% 201
2024
Q4 		$345K Sell
3,463
-555
-14% -$57.2K 0.05% 204
2024
Q3 		$456K Buy
4,018
+504
+14% +$59.9K 0.06% 192
2024
Q2 		$435K Sell
3,514
-101
-3% -$13K 0.07% 172
2024
Q1 		$477K Sell
3,615
-76
-2% -$9.37K 0.08% 148
2023
Q4 		$402K Buy
3,691
+85
+2% +$8.82K 0.07% 150
2023
Q3 		$371K Sell
3,606
-89
-2% -$9.59K 0.08% 143
2023
Q2 		$426K Buy
3,695
+99
+3% +$11.2K 0.09% 137
2023
Q1 		$383K Sell
3,596
-220
-6% -$23.8K 0.08% 137
2022
Q4 		$423K Buy
+3,816
New +$390K 0.08% 136

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Per Stirling Capital Management's MRK Position: Q1 2026 in Review

Per Stirling Capital Management increased its Merck (MRK) stake by 3.6% in Q1 2026, buying an estimated $15.2K and bringing the position to 3,769 shares worth $453K. The position accounts for 0.05% of the portfolio, ranked #209.

Per Stirling Capital Management first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $477K in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Per Stirling Capital Management held 3,769 shares of Merck worth $453K as of Q1 2026.
  • Per Stirling Capital Management bought 132 Merck shares in Q1 2026, an estimated $15.2K.
  • Merck made up 0.05% of Per Stirling Capital Management's portfolio in Q1 2026, its #209 holding.
  • Per Stirling Capital Management first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • Per Stirling Capital Management's Merck position peaked at $477K in Q1 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Per Stirling Capital Management's 13F filing for Q1 2026, filed 12 May 2026.